Cardiovascular health in transgender people

@article{Irwig2018CardiovascularHI,
  title={Cardiovascular health in transgender people},
  author={M. Irwig},
  journal={Reviews in Endocrine and Metabolic Disorders},
  year={2018},
  volume={19},
  pages={243-251}
}
  • M. Irwig
  • Published 2018
  • Medicine
  • Reviews in Endocrine and Metabolic Disorders
This review examines the relationship between exogenous sex steroids and cardiovascular events and surrogate markers in trans (transgender) people. Data from trans populations is compared to data from postmenopausal women and hypogonadal men when appropriate. In an age-adjusted comparison with cisgender people, trans people appear to have an increased risk for myocardial infarction and death due to cardiovascular disease. It is uncertain whether hormone therapy in trans people affects their… Expand
Cardiovascular disease in transgendered people: A review of the literature and discussion of risk
  • L. Seal
  • Medicine
  • JRSM cardiovascular disease
  • 2019
Emerging topics in transgender medicine
  • V. Tangpricha
  • Medicine
  • Reviews in Endocrine and Metabolic Disorders
  • 2018
Pathophysiological effects of androgens on the female vascular system
Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen
Health considerations for transgender women and remaining unknowns: a narrative review
Sex hormones, aging and cardiometabolic syndrome
Physiological and Metabolic Characteristics of a Cohort of Transgender and Gender-Diverse Youth in the United States.
Androgens’ effects on cerebrovascular function in health and disease
...
1
2
3
4
...

References

SHOWING 1-10 OF 49 REFERENCES
Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta‐Analysis
Long-term evaluation of cross-sex hormone treatment in transsexual persons.
Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study.
Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
Postmenopausal Hormone Therapy and Risk of Stroke
Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia.
Hormone therapy for preventing cardiovascular disease in post-menopausal women.
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
...
1
2
3
4
5
...